Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Biomarker Study of the Effects of Dexpramipexole on Eosinophils in Subjects With Eosinophilic Asthma

NCT04046939 is registered in ClinicalTrials.gov with Knopp Biosciences as lead sponsor.

NCT NCT04046939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04046939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Biomarker Study of the Effects of Dexpramipexole on Eosinophils in Subjects With Eosinophilic Asthma
Lead sponsor
Knopp Biosciences
Phase
Phase 2
Overall status
Completed
Start date
August 15, 2019
Completion date
March 2, 2021
Enrollment
534 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, eosinophilic asthma